Funding
Support from institutional, federal and foundation sources helps support our work, including the loading of reagents into a 96-well plate with a multichannel pipette.
Dr. Fairweather has received funding for research in her Translational Cardiovascular Disease Research Laboratory from a variety of organizations, including the National Institutes of Health (NIH), the National Heart, Lung, and Blood Institute (NHLBI), and Mayo Clinic. Here are some of her recent grants.
| Investigator & Role |
Grant Title |
Funding Source |
Duration |
| DeLisa Fairweather, Ph.D., co-investigator |
Distinct pathways of VPF/VEGF receptors |
NIH, NHLBI (R01 HL140411) |
4/1/2018-3/31/2023 |
| DeLisa Fairweather, Ph.D., co-investigator |
Autoimmune mechanisms in human myocarditis |
NIH, NHLBI (R01 HL135165) |
1/1/2017-12/31/2021 |